Pull 4 Parkinson’s Foundation, Inc., a registered 501(c)(3) public charity,
funds cure and care research conducted by the Parkinson's disease community.
Learn More or Donate.

63 Parkinson’s Trials Are Not Yet Recruiting

Trial Name Last Updated
Effectiveness of Ropinirole and Gabapentin for the Treatment of RLS in Patients on Maintenance HD 10/26/2018
Movement Disorders and Early Maladaptive Schemas 10/24/2018
A Study to Assess the Safety of GRF6021 Infusions in Subjects With Parkinson's Disease and Cognitive Impairment 10/22/2018
The Relationship Between Neuropsychological Testing and MRI, PET and COBRE - Project 1: AIM 2 (GE-180) 10/11/2018
Acceptability of Palliative Care in Parkinson Disease Care 10/05/2018
The Effects of Adding Expiratory Muscle Strength Training in Voice Therapy 10/02/2018
Study of the Fecal Microbiome in Patients With Parkinson's Disease 09/28/2018
A Study to Evaluate in Patients With Parkinsonian Type Disorders 09/25/2018
Study of Neurodegenerative Diseases Induced Stem Cells in Patients and Healthy Family Controls. 09/24/2018
Progression of Prodromal Markers of α-synucleinopathy Neurodegeneration in the FDRs of Patients With RBD 09/20/2018
Dopamine Effect on Inhibitory Control 09/12/2018
Use of Low-dose Zolpidem in Parkinson's Disease 08/21/2018
Utilizing Smart Devices to Identify New Phenotypical Characteristics in Movement Disorders 08/20/2018
Standardization and Optimization of TMS Protocols for the Treatment of PD With Depression or Cognitive Impairment 07/24/2018
Effects of Lingzhi on Disease Progression in Patients With Untreated Early Parkinson's Disease 07/20/2018
Aqua Stand-Up Paddle Balance Effect in Parkinson's Disease (AquaSUP PARK) 07/11/2018
To Assess the Efficacy and Safety of Ceftriaxone in Patients With Mild to Moderate Parkinson's Disease Dementia 07/11/2018
Diabetes as an Accelerator of Cognitive Impairment and Alzheimer's Disease 07/06/2018
Microbiota Intervention to Change the Response of Parkinson's Disease 07/02/2018
Imaging Neuromelanin and Iron in Dystonia/Parkinsonism 06/28/2018
Study of Clonidine Efficacy for the Treatment of Impulse Control Disorders in Parkinson's Disease: 06/25/2018
A Randomized Controlled Trial of Nicotinamide Supplementation in Early Parkinson's Disease: the NOPARK Study 06/25/2018

Page 1 of 3 pages  1 2 3 > 

All ClinicalTrials.gov articles provided courtesy of National Library of Medicine (NLM).